tapebrief
AMCR · Q4 2025
AMCR · Q2 2026
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

AMCR · Q1 2026 Earnings

Amcor

Reported November 5, 2025

30-second summary

Amcor delivered Q1 FY2026 non-GAAP EPS of $0.193 (+18% YoY constant currency), landing at the top of the $0.18–0.20 guide, with $38M of Berry synergies realized at the upper end of the $35–40M range. Management reaffirmed the full FY26 EPS guide of $0.80–0.83 and elevated synergy language from "approximately $260M" to "at least $260M" — explicitly stating the 12–17% EPS growth target is not contingent on any macro or demand improvement. The Q2 EPS guide of $0.16–0.18 reflects acknowledged December-quarter seasonality in the legacy Berry business, with synergy contribution accelerating to $50–55M.

Headline numbers

EPS

Q1 FY2026

$0.19

Revenue

Q1 FY2026

$5.75B

+68.0% YoY

Gross margin

Q1 FY2026

19.6%

Free cash flow

Q1 FY2026

$-0.34B

Operating margin

Q1 FY2026

8.0%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$5.75B+68.0%$5.08B+13.0%
EPS$0.19—$0.20-3.5%
Gross margin19.6%—17.6%+200bps
Operating margin8.0%—1.7%+630bps
Free cash flow$-0.34B—$0.94B-136.4%

Guidance

Company reaffirmed full-year FY2026 EPS and free cash flow guidance while delivering Q1 results at the high end of expectations, with synergy execution ahead of schedule.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
EPS (non-GAAP)Q1 FY2026$0.18–0.20$0.193+0.3–1.3 cents above guideBeat
Synergy benefitsQ1 FY2026$35–40 million$38 millionin-line / at upper end of expected rangeBeat

New guidance

MetricPeriodGuideYoY
EPS (non-GAAP)Q2 FY2026$0.16–0.18—
Synergy benefitsQ2 FY2026$50–55 million—

Segment KPIs

Q1 FY2026
SegmentQ1 FY2026YoY
Global Flexible Packaging Solutions$3.257B+25.0%
Global Rigid Packaging Solutions$2.488B+205.0%

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Adjusted EBITDA$909 million
Adjusted EBIT Margin12.0%
Synergies Realized (Q1)$38 million
Global Flexible Packaging EBIT Margin13.1%
Global Rigid Packaging EBIT Margin11.9%
Adjusted EPS (constant currency growth)19.3 cents
Net Debt$13,999 million
FY2026 Adjusted EPS Guidance80-83 cents

Management tone

Q4 FY25 stabilization-and-pruning posture → Q1 FY26 synergy overdelivery and macro decoupling.

Last quarter framed FY26 as "synergies covering for flat volumes in a soft market." This quarter explicitly removes the macro from the equation. In Q4, management said they were "not factoring in a meaningful rebound in consumer demand … given the current macroeconomic environment." This quarter the framing tightened to: "achieving our guidance for 12 to 17% EPS growth this year is not dependent on improvements in the macroeconomic environment or in customer or consumer demand." The shift from "we're not counting on it" to "we don't need it" repositions Amcor as a structural earnings story rather than a cyclical packaging name — a material change in how the bull case should be underwritten.

Synergy language hardened from "approximately" to "at least" — a small word change that matters. Last quarter's $260M FY26 synergy target was framed as a plan to execute against. This quarter it became a floor: "we have clear line of sight to opportunities that will drive at least $260 million in synergy benefits … we said now we're saying it's at least $260 million." Combined with Q1 landing at the upper end of the synergy range and Q2 guided to $50–55M (a step-up that implies front-loaded, not back-end-loaded, capture), the execution risk that hung over the Q4 print has materially reduced.

Revenue synergies moved from pipeline to booked. Q4 discussed cross-selling as future opportunity. This quarter management cited "revenue synergies totaling more than $70 million in annualized sales" as already secured — within 180 days of close. The cost synergy thesis was always the easier part of the Berry case; tangible revenue synergy proof points this early are the harder part landing.

Volume framing shifted from accepting decline to flagging upside scenarios. Q4 baked in flat volumes; this quarter introduced: "there is actually an opportunity for the volumes to be positive in the back half of the fiscal year." Hedged but new — and grounded in internal initiatives rather than market recovery.

Notably absent from the press release: any update on the North American beverage divestiture process flagged at Q4. The Rigid segment EBIT margin of 11.9% suggests the unit is being run more cleanly than the Q4 commentary implied, but the strategic status — divest, retain, transform — is unaddressed in available source material.

Recurring themes management leaned on this quarter:

Synergy overdelivery and acceleration momentumEPS growth decoupled from macro conditionsRevenue synergies materializing faster than expectedDisciplined cost and capacity management offsetting volume headwindsPortfolio optimization and non-core asset divestmentsSystem solutions and cross-selling driving incremental growth

Risks management surfaced:

Macroeconomic uncertainty and consumer demand volatilityOngoing volume pressure in developed markets (North America and Europe)Weakness in unconverted film category in EuropeHealthcare pharma exposure softer in EuropeMeat and protein category cycle weakness

Answers to last quarter's watch list

North American beverage divestiture pathway — The press release does not address divestiture timeline or process initiation. The Rigid Packaging segment delivered 11.9% EBIT margin, suggesting operational stabilization vs. Q4's flagged underperformance, but the strategic question of whether the $1.5B unit is being prepared for sale, transformed, or retained remains unaddressed in available source material.
Continue monitoring
Synergy realization run-rate — $38M realized in Q1 (upper end of $35–40M guide) and $50–55M guided for Q2 puts H1 synergy capture at $88–93M, or 34–36% of the $260M FY target through 50% of the year. This is essentially on a linear cadence with slight acceleration into Q2, not back-end-loaded. Management firmed the FY framing to "at least $260M.".
Resolved positively
Adjusted EBIT margin trajectory — Q1 EBIT margin held at 12.0%, exactly matching Q4 FY25, despite management's prior warning that North American beverage costs would remain elevated in Q1. Gross margin expanded 200bps to 19.6%. The line held.
Resolved positively
Free cash flow conversion — Q1 FCF was $(343)M, consistent with the seasonal pattern flagged at Q4 for the legacy Berry business. FY26 guide of $1.8–1.9B was reaffirmed, meaning the cash generation is expected almost entirely in H2. This is on-plan but back-end loaded, which keeps execution risk elevated for the FY conversion target.
Continue monitoring
Leverage and capital allocation — Net debt disclosed at $13,999M; no leverage ratio or net debt/EBITDA multiple explicitly cited in extraction, and no commentary on buyback or M&A re-entry.
Continue monitoring

What to watch into next quarter

Q2 synergy delivery against $50–55M guide: A print at or above the upper end would all but lock the FY26 "at least $260M" framing; a miss below $50M would be the first execution slip and re-open the back-end-loading risk.

H2 volume trajectory: Management floated positive volumes in the back half. Watch the Q2 print for any concrete commentary on order book or customer behavior supporting that hedged upside — or a quiet retreat from the framing.

North American beverage status: Five quarters into the Berry combination, silence on the divestiture process becomes its own signal. Watch for an explicit strategic update, write-down, or formal sale process announcement.

FCF cadence into H2: With Q1 at $(343)M and FY guide at $1.8–1.9B, H2 needs to generate roughly $2.1–2.2B. Watch Q2 FCF for the inflection point — a second consecutive cash burn quarter materially raises FY conversion risk.

Revenue synergy build vs. the $70M annualized base: New business wins beyond the $70M would validate the revenue synergy thesis as compounding, not one-time pent-up demand from cross-sell introductions.

Sources

  1. Amcor Q1 FY2026 press release: https://www.sec.gov/Archives/edgar/data/1748790/000174879025000034/exhibit991q12026.htm
  2. Amcor Q4 FY2025 brief (tapebrief prior coverage, for trend context).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.